Article
Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle.
Clinical and experimental pharmacology & physiology - 1 Feb 2016
Hermes Túlio de Almeida, Macedo Aline Barbosa, Fogaça Aline Reis, Moraes Luis Henrique Rapucci, de Faria Felipe Meira, Kido Larissa Akemi, Cagnon Valéria Helena Alves, Minatel Elaine
Abstract excerpt
This study evaluated the possible protective effects of cilostazol against myonecrosis in dystrophic diaphragm muscle in vivo, focusing on oxidative stress, the inflammatory response and angiogenesis. Young mdx mice, the experimental animal for Duchenne muscular dystrophy, received cilostazol for 14 days. A second group of mdx mice and a control group of C57BL/10 mice received a saline solution. In the mdx mice,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
